Recommended tests for patients with T-PLL
| Assessments . | General practice . | Trials . |
|---|---|---|
| To establish diagnosis | ||
| History, physical examination | Always | Always |
| Blood count and differential count | Always | Always |
| Bone marrow aspirate and biopsy | When clinically indicated | Desirable |
| Biopsy or aspirate of suspected involved site | When clinically indicated | Desirable |
| Immunophenotyping of blood lymphocytes | Always | Always |
| T-cell receptor rearrangement (TRB, TRG) | Always | Always |
| chromosome banding analysis | Desirable | Desirable |
| Fluorescence in situ hybridization (FISH) | Desirable | Desirable |
| Testing for HTLV | Always* | Always* |
| Before treatment start and at response assessment | ||
| CIRS,† physical examination, performance status | Always | Always |
| Blood count and differential count | Always | Always |
| Bone marrow aspirate and biopsy‡ | Always | Always |
| Serum chemistry | Always | Always |
| Infectious disease status (HBV, HCV, HIV, HSV)† | Always | Always |
| Serum lactate dehydrogenase | Always | Always |
| b2-microglobulin | Desirable | Always |
| CT scan of neck, chest, abdomen, pelvis | Always | Always |
| PET scans | Not generally indicated | Not generally indicated |
| Chest radiograph | Not generally indicated | Not generally indicated |
| Abdominal ultrasound | Not generally indicated | Not generally indicated |
| Next-generation sequencing, MRD | Not generally indicated | Desirable |
| Assessments . | General practice . | Trials . |
|---|---|---|
| To establish diagnosis | ||
| History, physical examination | Always | Always |
| Blood count and differential count | Always | Always |
| Bone marrow aspirate and biopsy | When clinically indicated | Desirable |
| Biopsy or aspirate of suspected involved site | When clinically indicated | Desirable |
| Immunophenotyping of blood lymphocytes | Always | Always |
| T-cell receptor rearrangement (TRB, TRG) | Always | Always |
| chromosome banding analysis | Desirable | Desirable |
| Fluorescence in situ hybridization (FISH) | Desirable | Desirable |
| Testing for HTLV | Always* | Always* |
| Before treatment start and at response assessment | ||
| CIRS,† physical examination, performance status | Always | Always |
| Blood count and differential count | Always | Always |
| Bone marrow aspirate and biopsy‡ | Always | Always |
| Serum chemistry | Always | Always |
| Infectious disease status (HBV, HCV, HIV, HSV)† | Always | Always |
| Serum lactate dehydrogenase | Always | Always |
| b2-microglobulin | Desirable | Always |
| CT scan of neck, chest, abdomen, pelvis | Always | Always |
| PET scans | Not generally indicated | Not generally indicated |
| Chest radiograph | Not generally indicated | Not generally indicated |
| Abdominal ultrasound | Not generally indicated | Not generally indicated |
| Next-generation sequencing, MRD | Not generally indicated | Desirable |